China Approves Sinopharm's Covid Vaccine for General Use
Dec.30 -- China approves the country’s first coronavirus vaccine for general public use. China’s National Medical Products Administration gave its approval to a Covid-19 vaccine developed by state-owned China National Biotec Group Co., unit of pharmaceutical giant Sinopharm. Tom Mackenzie reports on "Bloomberg Markets: Asia."